Investigational gene therapy for medically refractory Parkinson’s shows promiseOctober 29, 2018Movement DisordersParkinson's DiseaseNeurosurgery & TraumaGene Therapy
Many oromandibular dystonia patients report improvement after botulinum toxin injectionsOctober 29, 2018Movement Disorders
Objective studies help identify Parkinson’s patients at risk for fallsOctober 21, 2018Movement Disorders
Physiologically functional organoid offers promise for rapid, realistic in vitro drug discoveryOctober 20, 2018Movement Disorders
Imaging of child basal ganglion lesions yields useful clinical informationOctober 20, 2018PediatricsMovement Disorders
Novel imaging may differentiate dementia in Parkinson’sOctober 20, 2018Movement DisordersParkinson's Disease
Antiepileptic drug shows neuroprotection in Parkinson’sOctober 20, 2018Movement DisordersParkinson's Disease
Supplement combo buffers against PD neurodegeneration in rodent modelOctober 19, 2018Movement Disorders
Open mind essential to tackling diverse symptoms of Parkinson’sOctober 19, 2018Movement DisordersParkinson's Disease
Sensory feedback modalities tackle gait, balance problems in PDOctober 19, 2018Movement DisordersParkinson's Disease
Several PT modalities are useful in Parkinson’s, movement disordersOctober 14, 2018Movement Disorders
3-D model neurovascular unit developed with working blood-brain barrierOctober 13, 2018Movement Disorders
Huntington’s progression tracks with levels of mutant huntingtin, neurofilament lightSeptember 12, 2018Movement DisordersRare DiseasesHuntington's Disease
